Overview

Not every patient with hair loss wants an injection. For some, the preference is clear and consistent: they want meaningful treatment, they want it to be effective, and they would like it to not involve a needle entering their scalp. For many years, the honest clinical response to this preference was that the most effective biological hair restoration treatments all required injection. Topical options existed, but the ceiling of what topical application could achieve through an intact scalp was limited by the same barrier limitations that restrict all topical treatment.

Laser Hair Restart changes this. It delivers its biological stimulus through light — photobiomodulatory energy at a precisely calibrated wavelength and intensity that penetrates to the depth of the follicular bulge region without breaking the skin surface at any point. The follicular stem cells in the bulge region receive the light energy, absorb it at the molecular level, and respond with increased biological activity — increased ATP production, improved cellular metabolism, stimulated stem cell differentiation toward hair matrix cells — producing the same type of follicular reactivation that injectable biological treatments stimulate through growth factor delivery. A different mechanism. A comparable biological goal. And no needle involved at any point.

The Fotona SP Dynamis Er:YAG laser used for Hair Restart at Ministry of Skin delivers photobiomodulatory energy at 2940nm — chosen for its optimal penetration to the follicular bulge depth without ablating the scalp surface. Treatment parameters are set below the ablative threshold at every point, ensuring that the energy delivered is photobiomodulatory — stimulating cellular biological activity — rather than photothermal in the tissue-damaging sense.

What Photobiomodulation Does to the Follicle

In hair restoration, the relevant chromophore — the molecular target that absorbs the laser energy — is cytochrome c oxidase, a key enzyme in the mitochondrial electron transport chain. When cytochrome c oxidase absorbs photobiomodulatory energy, it produces increased ATP — the cellular energy currency — and initiates a cascade of secondary effects: improved reactive oxygen species regulation, increased nitric oxide release with consequent perifollicular vasodilation, and the stimulation of transcription factors that drive follicular cell proliferation and hair shaft production. The follicular stem cells, dermal papilla cells, and perifollicular endothelial cells that receive this energy respond with measurably increased activity — the anagen growth phase is extended, the telogen resting phase is shortened, blood supply to the follicle improves, and growth factor production by the follicular cells themselves is upregulated.